Schizophrenia Treatment with Latuda

Efficacy and Safety

• The American Academy of Child and Adolescent Psychiatry suggests that Latuda has demonstrated efficacy for both positive and negative symptoms of schizophrenia 1

Treatment Algorithm

• The Lancet Psychiatry recommends assessing response after 4-6 weeks of treatment at an adequate dose, and considering dose increase up to 160 mg/day if inadequate response but good tolerability 2, 3
• The Lancet Psychiatry also suggests considering switching to another second-generation antipsychotic if treatment fails or intolerable side effects occur, and considering clozapine as per established guidelines for treatment-resistant cases 2, 3

Monitoring Recommendations

• The American Academy of Child and Adolescent Psychiatry recommends baseline and follow-up assessments, including documentation of target symptoms, laboratory monitoring, monitoring for extrapyramidal symptoms, and weight and metabolic parameter monitoring 3, 6
• The Lancet Psychiatry suggests regular assessment of treatment response and side effects is essential for optimal management, including monitoring for weight and metabolic parameters 2, 6

Combination Therapy

• The National Institute of Health may recommend antipsychotic monotherapy, but some treatment-resistant cases may benefit from carefully selected antipsychotic combinations under specialist supervision, as suggested by Drugs 4, 5